Pediatric Oncology Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
SECTION HEADS
Section Topics
- » Acute lymphoblastic leukemia
- » Biology of leukemia
- » Biology of solid tumors
- » Bone tumors
- » Brain tumors
- » Epidemiology and etiology
- » Germ-cell tumors and retinoblastoma
- » Histiocytosis
- » Hodgkin's disease
- » Imaging
- » Late effects in treatments
- » Liver tumors
- » Myelodysplasias
- » Neuroblastoma and variants
- » New methodology in surgery, and systemic chemotherapy and radiotherapy
- » Non-Hodgkin's lymphoma
- » Other rare tumors
- » Palliative care
- » Soft tissue sarcoma
- » Supportive medical care
- » Supportive pyschosocial care (incl. complementary medicine)
- » Tumor pathology
- » Wilms and other kidney tumors
LATEST RECOMMENDATION
Eric Nestler and Anne Schaefer, Mount Sinai School of Medicine, USA. F1000 Neuroscience
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
1 Recommendation, most recent by
Eric Nestler and Anne Schaefer, Mount Sinai School of Medicine, USA. F1000 Neuroscience
- New Finding
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

